- RecruitingPHASE1, PHASE2
A FIH, Phase I/IIa, Trial Assessing Feasibility of Administrations of TIL-based Immunotherapy in Patients With Metastatic CRC and PC
This early-stage study is testing a new type of immunotherapy called CC-38 for people with advanced bowel cancer or prostate cancer. It uses your own immune cells to try and fight the cancer. We want to see if this treatment is safe and effective.
For: Metastatic Colorectal Cancer · Prostate Cancer Metastatic · Prostate Cancer Locally AdvancedGermany - Active not recruitingPHASE1
"Re-Stimulated" TILs and IL-2 Therapy for Platinum Resistant Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
This study is for women with advanced ovarian, fallopian tube, or peritoneal cancer that has come back and isn’t responding to standard chemotherapy. It’s testing a new approach using special immune cells from your own body, called TILs, along with other treatments to see if they can fight the cancer.
For: Recurrent · Platinum-resistant · High Grade Serous Ovarian CancerCanada